A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease.

Read more about how low testosterone levels are linked to ‘extreme’ disease progression in patients with prostate cancer ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Results challenge view that high testosterone fuels prostate cancer growth ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers say they've developed a urine test that could answer whether prostate cancer is aggressive and requiring immediate ...

In a recent study published in the British Journal of Sports Medicine, researchers investigate the relationship between changes in adult cardiorespiratory fitness (CRF) and the incidence and mortality ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

The new study might have you rethinking the plastic water bottle you're holding.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene ...